Posted on 05/18/2020 1:34:15 PM PDT by AU72
My experience is that by the time the people get in the hospital their comorbitities make the HCQ a non-starter. This is what I hear from docs on a daily hospital update call (my wife still works at the hospital and she is on this call every morning.)
The hospital makes almost nothing on their pharmaceutical stuff. The same margin is applied to an aspirin as is applied to remdisever (sic). The profit margin at the hospital level (read docs) is not as big a deal as most people think. Hospitalists do not get a cut. They are employeesjust like the housekeeper or janitor. They make NOTHING based on what they prescribe.
All medicines are assigned a CMS code. Insurance companies will base their co-pays on the CMS number. In essence, the CMS system sets the pay standards for hospitals. If you are under the illusion that hospitals are not socialized already, you need to rethink that.
The pharma money comes from specialized treatments like chemo.
What I DO know about Docs is they are very concerned about giving a patient something that might hurt them. Its not an altruistic appeal to the Hippocratic oathits paranoia from malpractice.
My bet is if the insurance companies waived potential damage from HCQ you would see it rolled in quickly. Without that FDA approval for specific treatment you will have a hard time getting a lot of folks to jump on the wagon when the eventual outcome is not that different. The big difference is the time it takes to get to that outcome.
To the people responsible for providing care the liability of getting them fixed fast is outweighed by the likely outcome, albeit more slowly.
Geez, watched Cavuto ranting that EVERYONE IS GONNA DIEEE! THEY’RE GONNA DIEEEE! DIE! DIE! DIE!
What a nut. FOX needs to send him over to CNN.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.